GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Xcell Therapeutics Inc (XKRX:373110) » Definitions » Institutional Ownership

Xcell Therapeutics (XKRX:373110) Institutional Ownership : 0.04% (As of May. 06, 2025)


View and export this data going back to 2024. Start your Free Trial

What is Xcell Therapeutics Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Xcell Therapeutics's institutional ownership is 0.04%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Xcell Therapeutics's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Xcell Therapeutics's Float Percentage Of Total Shares Outstanding is 0.00%.


Xcell Therapeutics Institutional Ownership Historical Data

The historical data trend for Xcell Therapeutics's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Xcell Therapeutics Institutional Ownership Chart

Xcell Therapeutics Historical Data

The historical data trend for Xcell Therapeutics can be seen below:

2024-09-30 2024-10-31 2024-11-30 2024-12-31 2025-01-31 2025-02-28 2025-03-31 2025-04-30
Institutional Ownership 0.04 0.04 0.04 0.04 0.04 0.04 0.04 0.04

Xcell Therapeutics Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


Xcell Therapeutics Business Description

Traded in Other Exchanges
N/A
Address
333, Yeongdong-daero, Gangnam-gu, Seoul, KOR, 06188
Xcell Therapeutics Inc operates as a research company engaged in development of regenerative medicines. The company is developing proliferation media for various animal cell types.

Xcell Therapeutics Headlines

No Headlines